Immunoprecise Stock Price on July 5, 2022 Breakdown


USD 5.30  0.21  3.81%   

As of today, the current price of Immunoprecise Antibodies is  5.30 , as last reported on the 16th of August 2022, with the highest price reaching  5.50  and the lowest price hitting  5.08  during the day.
Immunoprecise Antibodies appears to be moderately volatile, given 3 months investment horizon. Immunoprecise Antibodies holds Efficiency (Sharpe) Ratio of 0.0569, which attests that the entity had 0.0569% of return per unit of risk over the last 3 months. Our standpoint towards determining the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Immunoprecise Antibodies, which you can use to evaluate the future volatility of the firm. Please utilize Immunoprecise Antibodies' Risk Adjusted Performance of 0.1144, market risk adjusted performance of 0.3449, and Downside Deviation of 4.49 to validate if our risk estimates are consistent with your expectations.
As of August 16, 2022, Net Income Common Stock is expected to decline to about (17.1 M). Immunoprecise Antibodies Price to Book Value is projected to slightly decrease based on the last few years of reporting. The past year's Price to Book Value was at 1.81. The current year Price to Sales Ratio is expected to grow to 7.57, whereas Price to Earnings Ratio are forecasted to decline to (8.89) . Immunoprecise Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Most Recent Activity

Shares Float
20.8 M
Shares Outstanding
24.8 M
Shares Short Prior Month
200.6 K
Earnings Share
Shares Short
187.1 K
Revenue Per Share

Related Headline

Intel Corp Headline on 5th of July 2022

Intel A Contrarian Bargain Stock

Immunoprecise Antibodies Valuation on July 5, 2022

It is possible to determine the worth of Immunoprecise Antibodies on a given historical date. On July 5, 2022 Immunoprecise was worth 3.92 at the beginning of the trading date compared to the closed value of 3.95. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immunoprecise Antibodies stock. Still, in general, we apply an absolute valuation method to find Immunoprecise Antibodies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Visa where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immunoprecise Antibodies' related companies.
 Open High Low Close Volume
  3.99    3.99    3.82    3.84    1,767  
  3.92    4.01    3.83    3.95    12,863  
  3.83    4.02    3.81    3.94    13,021  
Backtest Immunoprecise Antibodies  |  Immunoprecise Antibodies History  |  Immunoprecise Antibodies Valuation   PreviousNext  
Open Value 3.92
Closing Value

Immunoprecise Antibodies Trading Date Momentum on July 5, 2022

On July 06 2022 Immunoprecise Antibodies was traded for  3.94  at the closing time. Highest Immunoprecise Antibodies's price during the trading hours was 4.02  and the lowest price during the day was  3.81 . The net volume was 13 K. The overall trading history on the 6th of July contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 0.25% . The trading delta at closing time to current price is 2.28% .

Immunoprecise Antibodies Fundamentals Correlations and Trends

By evaluating Immunoprecise Antibodies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immunoprecise Antibodies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immunoprecise financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Immunoprecise Antibodies Stock history

Immunoprecise Antibodies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunoprecise is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunoprecise Antibodies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunoprecise Antibodies historical stock prices may prove useful in developing a viable investing in Immunoprecise Antibodies
Last ReportedProjected for 2022
Weighted Average Shares19.7 M19.4 M
Weighted Average Shares Diluted19.7 M19.4 M
Issuance Purchase of Equity Shares3.9 MM
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada. Immunoprecise Antibodies operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

Immunoprecise Antibodies Quarterly Market Capitalization

108.2 Million

Immunoprecise Antibodies Stock Technical Analysis

Immunoprecise Antibodies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immunoprecise Antibodies technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immunoprecise Antibodies trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Immunoprecise Antibodies Period Price Range

July 5, 2022





Immunoprecise Antibodies August 16, 2022 Market Strength

Market strength indicators help investors to evaluate how Immunoprecise Antibodies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunoprecise Antibodies shares will generate the highest return on investment. By undertsting and applying Immunoprecise Antibodies stock market strength indicators, traders can identify Immunoprecise Antibodies entry and exit signals to maximize returns

Immunoprecise Antibodies Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Immunoprecise stock's direction in advance. Along with the technical and fundamental analysis of Immunoprecise Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunoprecise to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
131.6 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.